Original Research
Published on 28 Aug 2023
Establishment of a primary renal lymphoma model and its clinical relevance
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1089187
- 2,278 views
- 5 citations
Type at least 3 characters
1,836 articles
Review
Published on 28 Aug 2023
Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1196564
- 4,763 views
- 2 citations
Original Research
Published on 22 Aug 2023
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1230629
- 2,920 views
- 1 citation
Correction
Published on 21 Aug 2023
Corrigendum: High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1212991
- 1,279 views
Editorial
Published on 21 Aug 2023
Editorial: Case reports in hematological malignancies: 2022
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1272547
- 2,103 views
Original Research
Published on 21 Aug 2023
The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease’s phenotype
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1224590
- 3,473 views
- 1 citation
Editorial
Published on 21 Aug 2023
Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1275992
- 1,061 views
Original Research
Published on 18 Aug 2023
ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1200914
- 6,044 views
- 15 citations
Original Research
Published on 18 Aug 2023
Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1142449
- 2,536 views
- 2 citations
Editorial
Published on 17 Aug 2023
Editorial: Implementation of novel drugs and modern radiotherapy in the treatment of lymphoma patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1273598
- 976 views
Brief Research Report
Published on 16 Aug 2023
Targeted panel sequencing in the routine diagnosis of mature T- and NK-cell lymphomas: report of 128 cases from two German reference centers
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1231601
- 1,871 views
- 3 citations
Original Research
Published on 15 Aug 2023
Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1221782
- 2,279 views
- 5 citations
Original Research
Published on 14 Aug 2023
Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1217712
- 4,469 views
- 12 citations
Editorial
Published on 14 Aug 2023
Editorial: Advances in the treatment of primary central nervous system lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1271566
- 1,194 views
Original Research
Published on 11 Aug 2023
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1190305
- 2,898 views
- 1 citation
Original Research
Published on 10 Aug 2023
Validation of the FACT-G7 in patients with hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1183632
- 1,708 views
- 2 citations